Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial

Gadi Lalazar, Meir Mizrahi, Ilit Turgeman, Tomer Adar, Ami Ben Ya’acov, Yehudit Shabat, Assy Nimer, Nila Hemed, Lidya Zolotarovya, Yoav Lichtenstein, Nadya Lisovoder, Sarit Samira, Itamar Shalit, Ronald Ellis, Yaron Ilan

Research output: Contribution to journalArticlepeer-review

68 Scopus citations

Fingerprint

Dive into the research topics of 'Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology